Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
Current Oncology · 16.02.2023 · 30 (2) · 2366-2387
DOI: 10.3390/curroncol30020181 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 16.02.2023. Verfasst von Marco Russano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Campus Bio-Medico University of Rome, Via Álvaro del Portillo, 21, 00128 Rome, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunotherapy has revolutionized the treatment paradigm of non-small cell lung cancer and improved patients’ prognosis. Immune checkpoint inhibitors have quickly become standard frontline treatment for metastatic non-oncogene addicted disease, either as a single agent or in combination strategies. However, only a few patients have long-term benefits, and most of them do not respond or develop progressive disease during treatment. Thus, the identification of reliable predictive and prognostic biomarkers remains crucial for patient selection and guiding therapeutic choices. In this review, we provide an overview of the current strategies, highlighting the main clinical challenges and novel potential biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Campus Bio-Medico University of Rome, Via Álvaro del Portillo, 21, 00128 Rome, Italy.
- Division of Medical Oncology, San Camillo Forlanini Hospital, 00152 Roma, Italy.
ORCID-Profile: Alessandro Galletti
Zitieren
APA
Russano, M., La Cava, G., Cortellini, A., Citarella, F., Galletti, A., Di Fazio, G. R., Santo, V., Brunetti, L., Vendittelli, A., Fioroni, I., Pantano, F., Tonini, G., & Vincenzi, B. (2023). Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers. Current Oncology, 30(2), 2366-2387. https://doi.org/10.3390/curroncol30020181
Vancouver
Russano M, La Cava G, Cortellini A, Citarella F, Galletti A, Di Fazio GR, et al. Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers. Current Oncology. 2023;30(2):2366-2387. doi:10.3390/curroncol30020181
BibTeX
@article{Russano2023,
author = {Russano, Marco and La Cava, Giulia and Cortellini, Alessio and Citarella, Fabrizio and Galletti, Alessandro and Di Fazio, Giuseppina Rita and Santo, Valentina and Brunetti, Leonardo and Vendittelli, Alessia and Fioroni, Iacopo and Pantano, Francesco and Tonini, Giuseppe and Vincenzi, Bruno},
title = {Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {2},
pages = {2366--2387},
doi = {10.3390/curroncol30020181}
}
EUVIMED